These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2488113)

  • 1. Effects of pindolol and propranolol on blood lipids in hypertensive patients.
    Román O; Pino ME; Pereda T; Valenzuela A
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):767-70. PubMed ID: 2488113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
    Román O; Pino ME; Valenzuela A
    Cardiology; 1987; 74(3):219-25. PubMed ID: 3594511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
    Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of hydrochlorothiazide, propranolol and a combination of pindolol and clopamide in patients with essential hypertension].
    Meza N; López H; Román O
    Rev Esp Cardiol; 1989 May; 42(5):304-8. PubMed ID: 2772366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.
    Murphy MB; Sugrue D; Trayner I; Kaufman S; Yasuhara H; Dollery CT; Thompson GR
    Br Heart J; 1984 Jun; 51(6):589-94. PubMed ID: 6732988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
    Fogari R; Zoppi A; Corradi L; Preti P; Mugellini A; Lusardi P
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
    Pasotti C; Capra A; Fiorella G; Vibelli C; Chierichetti SM
    Br J Clin Pharmacol; 1982; 13(Suppl 2):435S-439S. PubMed ID: 7104157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
    Lehtonen A
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipid fractions during bopindolol treatment in hypertensive patients.
    van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S42-4. PubMed ID: 2439818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
    Chu D; Cocco G; Schweda E; Haeusler G; Strozzi C
    Eur J Clin Pharmacol; 1980 Aug; 18(2):141-6. PubMed ID: 7428794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
    Johnston GD; Finch MB; Shanks RG
    Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
    Lehtonen A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.
    Terént A; Ribacke M; Carlson LA
    Eur J Clin Pharmacol; 1989; 36(4):347-50. PubMed ID: 2737226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension.
    Samuel P; Chin B; Fenderson RW; Schoenfeld BH; Gonasun LM; Lieberman S
    Am J Cardiol; 1986 Feb; 57(5):24C-28C. PubMed ID: 3946247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patients.
    Sasaki N; Saito Y; Shinomiya M; Kanzaki T; Ishikawa Y; Mori S; Kobayashi J; Murano S; Nishide T; Morisaki N
    Clin Ther; 1990; 12(2):157-64. PubMed ID: 2354485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.